Department of Haematology and Oncology, Mackay Memorial Hospital, Taipei, Taiwan.
Palliat Med. 2013 Feb;27(2):185-91. doi: 10.1177/0269216311428777. Epub 2011 Nov 29.
Totally implantable port systems are generally recommended for prolonged central venous access in diverse settings, but their risk of complications remains unclear for patients with advanced cancer.
The aim of this study was to assess the risk of port system failure in patients with advanced cancer.
We conducted a retrospective cohort study in a comprehensive cancer centre.
SETTING/PARTICIPANTS: A detailed chart review was conducted among 566 patients with 573 ports inserted during January-June, 2009 (average 345.3 catheter-days). Cox regression analysis was applied to evaluate factors during insertion and early maintenance that could lead to premature removal of the port systems due to infection or occlusion.
Port system-related infection was significantly associated with receiving palliative care immediately after implantation (hazard ratio, HR = 7.3, 95% confidence interval, 95% CI = 1.2-46.0), after adjusting for probable confounders. Primary cancer site also impacted the occurrence of device-related infection. Receiving oncologic/palliative care (HR = 3.0, P = 0.064), advanced cancer stage (HR = 6.5, P = 0.077) and body surface area above 1.71 m(2) (HR = 3.4, P = 0.029) increased the risk of port system occlusion.
Our study indicates that totally implantable port systems yield a higher risk of complications in terminally ill patients. Further investigation should be carefully conducted to compare outcomes of various central venous access devices in patients with advanced cancer and to develop preventive strategies against catheter failure.
在各种情况下,完全植入式端口系统通常被推荐用于延长中心静脉通路,但它们在晚期癌症患者中的并发症风险尚不清楚。
本研究旨在评估晚期癌症患者中端口系统故障的风险。
我们在一家综合性癌症中心进行了一项回顾性队列研究。
设置/参与者:在 2009 年 1 月至 6 月期间,对 566 名患者的 573 个端口进行了详细的图表审查(平均导管天数为 345.3 天)。应用 Cox 回归分析评估了插入和早期维护期间可能导致端口系统因感染或阻塞而提前移除的因素。
端口系统相关感染与植入后立即接受姑息治疗显著相关(危险比,HR = 7.3,95%置信区间,95%CI = 1.2-46.0),在调整了可能的混杂因素后。原发癌部位也影响了器械相关感染的发生。接受肿瘤/姑息治疗(HR = 3.0,P = 0.064)、晚期癌症分期(HR = 6.5,P = 0.077)和体表面积超过 1.71 m²(HR = 3.4,P = 0.029)增加了端口系统阻塞的风险。
我们的研究表明,在终末期患者中,完全植入式端口系统的并发症风险更高。应仔细进行进一步调查,以比较各种中心静脉通路装置在晚期癌症患者中的结局,并制定针对导管故障的预防策略。